The National Cancer Institute (NCI) is offering a grant opportunity for conducting innovative cohort studies focusing on cancer survivors’ health outcomes. This grant supports the establishment of prospective cohort studies to address gaps in understanding the health status of cancer survivors, considering factors like clinical, genomic, lifestyle, and social aspects. Applicants need to propose research plans targeting specific scientific gaps, such as emerging treatments and less studied survivor populations. The grant consists of a Planning-Exploratory Phase (UG3) for recruitment and data collection planning, followed by an Implementation Phase (UH3). Proposed studies must encompass disease characteristics, individual survivor attributes, treatment effects, lifestyle factors, and quality of life outcomes, with milestones for the transition to the UH3 phase. Application deadline: July 7, 2020.
Opportunity ID: 326148
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-20-030 |
| Funding Opportunity Title: | Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors (UG3/UH3 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 08, 2020 |
| Last Updated Date: | Apr 08, 2020 |
| Original Closing Date for Applications: | Jul 07, 2020 |
| Current Closing Date for Applications: | Jul 07, 2020 |
| Archive Date: | Aug 12, 2020 |
| Estimated Total Program Funding: | $3,900,000 |
| Award Ceiling: | $750,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses Special district governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments County governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Public housing authorities/Indian housing authorities Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this Funding Opportunity Announcement (FOA), the NCI invites applications to support research in new and innovative cohort studies that identify clinical, lifestyle, genomic, and other factors that affect health outcomes (e.g., morbidity, mortality, quality of life, physical, social, and psychological outcomes) in cancer survivors. This RFA supports research that requires the creation of a new prospective cohort study of cancer survivors that addresses a gap in knowledge pertaining to the health of cancer survivors. Proposals must identify the scientific gap that the study addresses, which may include emerging treatments, less common cancer sites, and/or other understudied populations of cancer survivors with disparities. Sample size and proposed data collection must be driven by the scientific questions proposed and include information from the following five domains: 1) disease characteristics (e.g., type, stage), 2) individual survivor characteristics (e.g., comorbidities, SES, social connections, access to care measures), 3) treatment, treatment-related effects, and follow-up care (e.g. dose, adverse events, palliative care), 4) behavioral and lifestyle factors (e.g., diet, physical activity) and 5) quality of life outcomes (health related quality of life). These domains may represent exposures and/or outcomes, depending on the research questions, and should be measured at multiple timepoints, when appropriate. The UG3 Planning-Exploratory Phase focused on recruitment and data collection/utilization, and the UH3 Implementation Phase focused on completing the research agenda. Milestones to be accomplished in the UG3 phase for transition to the UH3 will be proposed by the PI, with approval by NCI, and must include a timeline for recruitment and show feasibility for data collection and analysis. Recruitment is not required to be completed in the UG3 phase, but reasonable progress should be demonstrated so that all aims will be completed in the UH3 phase. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-030.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020DO NOT USE: Package added in error | PKG00260857 | Jun 07, 2020 | Jun 16, 2020 | View | |
| FORMS-F-REVISED | Correct FORMS-F Package: Use for due dates on or after May 25, 2020 | PKG00262201 | Jun 16, 2020 | Jul 07, 2020 | View |
Package 1
Mandatory forms
326148 RR_SF424_2_0-2.0.pdf
326148 PHS398_CoverPageSupplement_5_0-5.0.pdf
326148 RR_OtherProjectInfo_1_4-1.4.pdf
326148 PerformanceSite_2_0-2.0.pdf
326148 RR_KeyPersonExpanded_2_0-2.0.pdf
326148 RR_Budget_1_4-1.4.pdf
326148 PHS398_ResearchPlan_4_0-4.0.pdf
326148 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
326148 RR_SubawardBudget30_1_4-1.4.pdf
326148 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
326148 RR_SF424_2_0-2.0.pdf
326148 PHS398_CoverPageSupplement_5_0-5.0.pdf
326148 RR_OtherProjectInfo_1_4-1.4.pdf
326148 PerformanceSite_2_0-2.0.pdf
326148 RR_KeyPersonExpanded_2_0-2.0.pdf
326148 RR_Budget10_1_4-1.4.pdf
326148 PHS398_ResearchPlan_4_0-4.0.pdf
326148 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
326148 RR_SubawardBudget10_30_1_4-1.4.pdf
326148 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
